Top 6 Reasons to Get Started with 1stOncology Today

1. Understand Your Oncology Competitive Landscape

1stOncology gives your team a focused, oncology-specific view of companies, drugs, targets, trials, deals, meetings, and scientific developments. With more than 25 years dedicated exclusively to oncology, the platform helps you monitor where competitors are moving, where new assets are emerging, and which signals may affect your strategy.

Track active organizations, drug candidates, clinical activity, scientific literature, and major oncology meetings in one curated intelligence layer, so your team can spend less time searching and more time interpreting what matters.

2. Identify Better BD&L and Partnering Opportunities

Use 1stOncology to find companies, assets, technologies, and academic opportunities aligned with your development or licensing goals. The platform connects deals, alliances, companies, targets, drugs, diagnostics, manufacturing relationships, and commercial opportunity projects to help you build sharper in-licensing, out-licensing, and collaboration shortlists.

With oncology-specific company intelligence and BD&L contacts, your team can move from broad scouting to targeted outreach faster.

3. Turn Oncology Signals into Actionable Strategy

WOncology moves quickly, and the challenge is not a lack of information. It is knowing which developments matter. 1stOncology helps convert fragmented events across press releases, trials, conferences, publications, regulatory updates, funding, and deals into structured signals your team can review, track, and act on.

This supports competitive monitoring, portfolio planning, clinical strategy, commercial assessment, and executive decision-making.

4. Strengthen Reports, Briefings, and Presentations

Whether preparing an internal strategy update, investor discussion, board deck, conference briefing, or competitive landscape report, 1stOncology helps you quickly access current, relevant, oncology-specific intelligence.

The result is stronger, more defensible output: better evidence trails, clearer market context, more complete company and asset views, and fewer last-minute manual searches.

5. Find the Right KOLs, Companies, Investors, and Contacts

1stOncology helps identify the people and organizations shaping a specific oncology field, including scientific and clinical experts, emerging companies, investors, collaborators, and BD contacts.

This makes it easier to understand who is influencing the space, who may be validating a target or modality, who is funding related innovation, and who may be worth engaging for scientific, clinical, commercial, or partnering reasons.

6. Make Every Major Oncology Meeting More Productive

1stOncologys Conference Intelligence helps your team track and interpret developments from major oncology meetings including AACR, ASCO, ASH, ESMO, and other specialized conferences.

Instead of sorting through meeting volume manually, users can connect abstracts, posters, drugs, targets, trials, companies, and emerging signals into a practical conference workflow. That means better preparation before the meeting, faster signal detection during the meeting, and stronger follow-up after the meeting.

1stOncology is more than an oncology database. It is a curated intelligence layer that helps teams see earlier signals, understand competitive movement, identify opportunities, and make faster, better-supported oncology decisions.